CD274 and squamous cell lung carcinoma: Our study evaluated PD-L1 expression in 51 lung ASCs, 133 lung adenocarcinomas, and 83 lung squamous cell carcinomas, and showed expression rates of 39.22%, 28.92%, and 13.53%, respectively.